Validating RNAseq-Signatures of Vorinostat (VOR) Sensitivity and Resistance in Patients with Newly Diagnosed Glioblastoma (GBM) Treated with VOR, Temozolomide and Radiation Therapy From Alliance N0874/ABTC-0902. Anderson, S. Keith , Miller, C. Ryan , Sarkaria, Jann N. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary - Primary - Neuro-Onc - N0874 , ABTC-0902
Alliance A071101: A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) Vaccine Given with Bevacizumab versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Bloch, Orin , Shi, Qian , Anderson, S. Keith , Knopp, Michael ... - SNO - Neuro-Oncology - 2017 Abstract - Primary - Primary - Neuro-Onc - A071101
Long term outcomes from intergroup NCCTG 86-72-51 (Alliance): Final report of a phase III prospective randomized trial of high dose versus low dose radiation therapy in adults with supratentorial low-grade glioma. Breen, William G. , Anderson, S. Keith , Carrero, Xiomara W ... - SNO - Neuro-Oncology - 2019 Abstract - Primary - Long-Term-Followup - Neuro-Onc - NCCTG-85-72-51
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance) Brown, Paul D. , Anderson, S. Keith , Carrero, Xiomara W. ... - - Neurooncol Pract - 2015 Manuscript - Primary - Long-Term-Followup - Neuro-Onc - NCCTG-86-72-51
NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases. Brown, Paul D. , Asher, Anthony L. , Ballman, Karla V. ... - SNO - Neuro Oncol - 2015 Abstract - Primary - Primary - Neuro-Onc - N0574
NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases Brown, Paul D. , Asher, Anthony L. , Ballman, Karla V. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Neuro-Onc - N0574
N107C/CEC.3 (Alliance/NCIC): Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease Brown, Paul D. , Ballman, Karla V. , Cerhan, Jane H. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Abstract - Primary - Primary - Neuro-Onc - N107C
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases Brown, Paul D. , Jaeckle, Kurt , Ballman, Karla V. , Farace, Elana ... - - JAMA - 2016 Manuscript - Primary - Primary - Neuro-Onc - N0574
Stereotactic Radiosurgery with or without Whole Brain Radiotherapy for Limited Brain Metastases: A Secondary Analysis of the NCCTG N0574 (Alliance) Randomized Controlled Trial Churilla, Thomas M. , Ballman, Karla V. , Brown, Paul D. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2017 Manuscript - Secondary - Primary - Neuro-Onc - N0574
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study Friday, Bret B. , Anderson, S. Keith , Buckner, Jan , Yu, Chunrong ... - - Neuro Oncol - 2012 Manuscript - Primary - Primary - Neuro-Onc - N0779
NCCTG N0872 (Alliance): A Randomized Placebo-Controlled Phase II Trial of Bevacizumab Plus Dasatinib in Patients with Recurrent Glioblastoma (GBM) Galanis, Evanthia , Anderson, S. Keith , Anastasiadis, Panagiotis Z. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Neuro-Onc - N0872
NCCTG N1174: Phase I/Comparative Randomized Phase II Trial of TRC105 plus Bevacizumab versus Bevacizumab in Bevacizumab-Naïve Patients with Recurrent Glioblastoma Multiforme (Alliance) Galanis, Evanthia , Anderson, S. Keith , Butowski, Nicholas ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Primary - Primary - Neuro-Onc - N1174
Phase II trial of vorinostat (VOR) combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (Alliance N0874/ABTC-0902) Galanis, Evanthia , Anderson, S. Keith , Miller, C. Ryan ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - Neuro-Onc - N0874
A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab plus Dasatinib in Patients with Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872 Galanis, Evanthia , Anderson, S. Keith , Twohy, Erin L. ... - - Cancer - 2019 Manuscript - Primary - Primary - Neuro-Onc - N0872
Local control after resection and adjuvant radiosurgery compared to radiosurgery alone for brain metastasis: Exploratory analysis of Alliance NCCTG N107C Hansen, Chase C. , Ballman, Karla V. , Anderson, S. Keith ... - ASTRO - Int J Radiation Biol Physics - 2020 Abstract - Secondary-not-in-original - Primary - Neuro-Onc - N107C
CODEL: Phase III study of RT alone, RT plus temozolomide, or temozolomide alone for newly diagnosed 1P/19Q codeleted anaplastic oligodendroglioma patients. Updated analysis from the initial study design (NCCTG N0577, Alliance) Jaeckle, Kurt A. , Ballman, Karla V. , van den Bent, Martin ... - SNO - Neuro-Oncology - 2020 Abstract - Primary - Other - Neuro-Onc - N0577
CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III randomized study of RT vs. RT+TMZ vs. TMZ for newly diagnosed 1p/19q-codeleted anaplastic glioma. Analysis of patients treated on the original protocol design Jaeckle, Kurt , Vogelbaum, Michael , Ballman, Karla ... - AAN - Neurology - 2016 Abstract - Primary - Comprehensive - Neuro-Onc - N0577
Randomized Placebo-Controlled Phase II Study of Dasatinib with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma (GBM), N0877 Laack, Nadia , Galanis, Eva , Anderson, S. Keith , Leinweber, Clinton ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Neuro-Onc - N0877
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K Ma, Daniel J. , Galanis, Evanthia , Anderson, S. Keith ... - - Neuro-oncology - 2015 Manuscript - Primary - Long-Term-Followup - Neuro-Onc - N057K
Effect of stereotactic radiosurgery compared to whole-brain radiotherapy for limited brain metastasis on long term cognition and quality of life: A pooled analysis of N107C/CEC.3 and N0574 randomized clinical trials (Alliance) Palmer, Joshua D. , Klamer, Brett G. , Ballman, Karla V. ... - ASTRO - Int J Radiation Biol Physics - 2020 Abstract - Secondary-not-in-original - Meta-Analysis - Health Outcome - N0574 , N107C
Stromal tumor infiltrating lymphocytes: In the Alliance N9831 trial STILS are prognostic of chemotherapy benefit but not predictive of trastuzumab benefit Perez, Edith A. , Ballman, Karla V. , Anderson, S. Keith ... - SABCS - Cancer Res. - 2015 Abstract - Secondary-not-in-original - Primary - Breast - N9831
C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial Perez, Edith A. , Jenkins, Robert B. , Dueck, Amylou C. ... - - J Clin Oncol - 2011 Manuscript - Secondary - Primary - Breast - N9831
Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial. Perez, Edith A. , Thompson, E. Aubrey , Anderson, S. Keith ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original - Primary - Breast - N9831
Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial Perez, Edith A. , Thompson, E. Aubrey , Ballman, Karla V. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Breast - N9831
Quality of Life Analysis of N0877 (Alliance): Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM) Qin, Rui , Tan, Angelina D. , Sloan, Jeff A. , Johnson, Derek Richard ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary - Primary - Health Outcome - N0877
N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group): Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease: Cognitive function of long-term survivors Roberge, David , Ballman, Karla V. , Cerhan, Jane H. ... - SNO - Neuro-Oncology - 2017 Abstract - Secondary - Primary - Neuro-Onc - N107C
Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients with Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572 Schiff, David , Jaeckle, Kurt A , Anderson, S. Keith ... - - Cancer - 2018 Manuscript - Primary - Primary - Neuro-Onc - N0572
Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (Alliance) Trifiletti, Daniel M. , Ballman, Karla V. , Brown, Paul D. ... - ASTRO - International Journal of Radiation Oncology • Biology • Physics - 2019 Abstract - Secondary-not-in-original - Primary - Neuro-Onc - N107C
